113 STAT. 1501A-492 PUBLIC LAW 106-113—APPENDIX G facilities, and pharmaceutical and biotechnology firms in the United States. (c) PARTICIPATION BY DEFENSE DEPARTMENT AND OTHER APPRO- PRIATE PERSONNEL. —The Secretary of Defense and, as appropriate, the Director of the Federal Bureau of Investigation shall make available specialized personnel to participate— (1) in each trial investigation or trial visit conducted pursuant to subsection (a); and (2) in each trial investigation or trial visit conducted pursuant to subsection (b), except for any investigation or visit in which the host facility requests that such personnel not participate, for the purpose of assessing the information security implications of such investigation or visit. The Secretary of Defense, in coordination with the Director of the Federal Bureau of Investigation, shall add to the report required by subsection (d)(2) a classified annex containing an assessment of the risk to proprietary and classified information posed by any investigation or visit procedures in the compliance protocol. (d) STUDY.— (1) IN GENERAL.— The President shall conduct a study on the need for investigations and visits under the compliance protocol to the Biological Weapons Convention, including— (A) an assessment of risks to national security and United States industry and research institutions of such on-site activities; and (B) an assessment of the monitoring results that can be expected from such investigations and visits. (2) REPORT.— Not later than the date on which a compliance protocol to the Biological Weapons Convention is submitted to the Senate for its advice and consent to ratification, the President shall submit to the Committee on Foreign Relations of the Senate a report, in both unclassified and classified form, setting forth— (A) the findings of the study conducted pursuant to paragraph (1); and (B) the results of trial investigations and trial visits conducted pursuant to subsections (a) and (b). Subtitle B—Nuclear Nonproliferation, Safety, and Related Matters SEC. 1131. CONGRESSIONAL NOTIFICATION OF NONPROLIFERATION ACTIVITIES. Section 602(c) of the Nuclear Non-Proliferation Act of 1978 (22 U.S.C. 3282(c)) is amended to read as follows: "(c)(1) The Department of State, the Department of Defense, the Department of Commerce, the Department of Energy, the Commission, and, with regard to subparagraph (B), the Director of Central Intelligence, shall keep the Committees on Foreign Relations and Governmental Affairs of the Senate and the Committee on International Relations of the House of Representatives fully and currently informed with respect to— "(A) their activities to carry out the purposes and policies of this Act and to otherwise prevent proliferation, including
�
